Seppo Ylä-Herttuala is one of the world’s leading gene therapy researchers. He is one of the few scientists who have been able to put his results to the test in late stage clinical trials. Ylä-Herttuala’s studies are aimed at discovering new treatments for severe cardiac ischemia and malignant brain tumours. They are based on completely novel methods, i.e. epigene therapy, vectors that are target-integrated into the genome, and antibody-producing gene transfer constructs that may have application in other medical fields, too.

Seppo Yla-Herttuala research interests include gene therapy.